Plus, news about Alebund Pharmaceuticals, Capsida Biotherapeutics, CytomX Therapeutics and Generation Bio:
Novo Nordisk’s latest obesity partner: The Danish pharma giant is teaming up with …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
The targeted therapy bezuclastinib was safe and rapidly reduced markers of disease burden while also improving symptoms for patients with a rare blood disorder called
SAN DIEGO — Investigational once-weekly insulin icodec outperformed once-daily insulin glargine U100 when it came to glycemic control in type 2 diabetes, the phase IIIa
The companies will develop gene therapies for ocular diseases under the new deal. Credit: elenavolf / Shutterstock.com. Otsuka Pharmaceutical has entered a multi-target partnership with